LAZARD ASSET MANAGEMENT LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$307
+429.3%
19,406
+27.4%
0.00%
Q1 2023$58
-100.0%
15,232
-48.2%
0.00%
Q2 2022$132,000
+109.5%
29,389
+161.1%
0.00%
Q3 2021$63,000
+34.0%
11,256
+93.8%
0.00%
Q1 2021$47,000
-93.5%
5,807
-92.1%
0.00%
-100.0%
Q2 2018$718,000
-7.5%
73,8580.0%0.00%0.0%
Q1 2018$776,000
+108.6%
73,858
+27.2%
0.00%0.0%
Q4 2017$372,00058,0860.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders